Citron Research Updates Emcore (EMKR)

March 25, 2008 1:26 PM EDT

Today, Citron Research updated its opinion of Emcore (Nasdaq: EMKR). Citron is a widely followed short seller who has written negative pieces on Arthrocare (Nasdaq: ARTC), Home Solutions (OTCBB: HSOA) and others in the past. Ostensibly, his next target is Emcore.

Citron said Emcore is reminiscent of Home Solutions. Home Solutions now trades for under a $1. Citron believes that Emcore needs to become profitable to fix its problems.

Also, Citron said, if Emcore's Green and Gold Energy is revealed to be an 'empty shell,' Citron said Emcore would in turn miss its earnings. [JT]
Citron Research

Sign up at EasyStockAlerts.com & Make Money Today!

The Disciplined Investor - Essential Strategies for Success


Related Categories

Insiders' Blog

Stocks Mentioned

ARTC 45.73

+1.60 +3.63%
Volume: 1,046,009
Track ARTC

EMKR 8.11

-0.02 -0.25%
Volume: 2,601,755
Track EMKR

HSOA 0.56

-0.03 -5.08%
Volume: 112,491
Track HSOA



Comments

CITRON DONT KNOW...
SEAN MCCABE on Mar 26, 2008 11:19 PM

THIER BUTT FROM A HOLE IN THE GROUND. ILL HOLD MINE, YOU SELL YOURS. ITS PUNKS LIKE THEM WHO MAKE THE BUY'N THAT MUCH BETTER. JUST LIKE THAT DORK DID TO ENER. IM GLAD I HELD THIERS. THANK YOU DORKS!!!


Add Your Comment